New Sleep Drug May Be Less Prone to Abuse
(HealthDay)


HealthDay - THURSDAY, Oct. 5 (HealthDay News) -- The sleep medication ramelteon (brand name Rozerem), recently approved in the United States to treat insomnia, does not appear to have potential for substance abuse or for motor or cognitive impairment, according to company-funded research.